Warwick Tong

Président chez AMPLIA THERAPEUTICS LIMITED Fortune : 228 755 $ au 31/05/2026

Profil

Warwick Tong currently works at Amplia Therapeutics Ltd., as Independent Non-Executive Chairman from 2018, Biomedical Research Australia, as Chairman, Amplia Therapeutics Uk Ltd., as Director, ACULEUS THERAPEUTICS PTY LTD, as Director, Pacalis Therapeutics Pty Ltd., as Director, Arc Centre For Excellence In Convergent Bio-Nano Science & Tec, as Member-Governance Board, and Maurice Wilkins Centre, as Member.
Dr. Tong also formerly worked at Oncology One Pty Ltd., as Chief Executive Officer & Director from 2011 to 2018, CTxONE, as Chairman from 2018 to 2020, Biomedical Research Victoria, as Chairman from 2018 to 2019, GlaxoSmithKline NZ Ltd., as Medical Director from 1993 to 1997, Glaxo Wellcome Manufacturing Pte Ltd., as Medical Director, Surface Logix LLC, as Senior Vice President-Development from 2010 to 2012, and GSK Plc, as Vice President-World Wide Development.
Dr. Tong received his graduate degree from Victoria University of Wellington.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
AMPLIA THERAPEUTICS LTD. 0,46%	06/09/2025	2 355 140 ( 0,46% )	228 755 $	31/05/2026

Postes actifs de Warwick Tong

Sociétés	Poste	Début
AMPLIA THERAPEUTICS LIMITED	Président	25/05/2018
Biomedical Research Australia	Président	-
Arc Centre For Excellence In Convergent Bio-Nano Science & Tec	Directeur/Membre du Conseil	-
Amplia Therapeutics Uk Ltd.	Directeur/Membre du Conseil	-
Maurice Wilkins Centre	Corporate Officer/Principal	-

Anciens postes connus de Warwick Tong

Sociétés	Poste	Fin
CTxONE	Directeur Général	-
Biomedical Research Victoria	Président	01/12/2019
Oncology One Pty Ltd.	Directeur Général	30/04/2018
Surface Logix LLC	Corporate Officer/Principal	03/10/2012
░░░░░░░░░░░░░░░ ░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░